The next decade
of biotech will be
decided in places
that have never had a lab.
We are building one of those places. This is what we believe, in our own words.
Biotechnology is no longer a question of capital or chemistry. It is a question of where founders can sit, who they sit next to, and whose money they raise on day one. The places that win the next decade will not be the ones that already have a lab. They will be the ones that build the first.
Saudi Arabia has committed $34.6 billion of non-oil GDP and eleven thousand jobs to biotechnology by 2040. The factories are being built. The capital is being committed. The labs that turn ideas into companies are not. We are building those labs.
We chose the city the Prophet ﷺ called Tayyibah — the wholesome. It was here that Al-Shifa bint Abdullah, whose own name means healing, taught the first generation of Muslims medicine, reading, and writing. Healing has been written into the name of this city for fourteen hundred years. The Madinah Knowledge Economic City masterplan already calls for a Centre for Medical Sciences and Biotechnology. We are the operating partner that activates that mandate.
Under the special-economic-zone framework administered by ECZA, foreign capital can — for the first time — hold equity in a project of this scale on this land. One-hundred-percent foreign ownership. Profits repatriated. Exit mechanics that institutions recognise. This window did not exist three years ago.
We are building one campus on four reinforcing engines: a wet-lab a founder walks into, a venture fund that capitalises her, a contract-research bench her company commissions, and the platform that introduces her to the world. Each engine stands alone. Together they compound. We are calling it the City of Healing because that is what this city has always been, and because we believe the next generation of medicines should be born here.